Rapid improvement of serum 1,5-anhydroglucitol concentrations after administration of alpha-glucosidase inhibitor.
Yoshioka
K
K
Azukari
K
K
Yoshida
T
T
Kondo
M
M
D015415:Biomarkers / Q000097:blood; D003847:Deoxyglucose / Q000097:blood* / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D007294:Inositol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007536:Isomerism; D008297:Male; D008875:Middle Aged
D015415:Biomarkers; D004791:Enzyme Inhibitors; D065089:Glycoside Hydrolase Inhibitors; D007294:Inositol; C006584:1,5-anhydroglucitol; D003847:Deoxyglucose; C102817:voglibose